HomeInsightsPE

Solara Active Pharma Sciences Ltd PE Ratio

Solara Active Pharma Sciences Ltd PE Ratio

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

8.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Solara Active Pharma Sciences Ltd

NSE: SOLARA

PE

-

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Solara Active Pharma Sciences Ltd is 0 as of 24 Nov 9.00 AM .
  • The P/E Ratio of Solara Active Pharma Sciences Ltd changed from 18.1 on March 2019 to 0 on March 2024 . This represents a CAGR of -100.00% over 6 years.
  • The Latest Trading Price of Solara Active Pharma Sciences Ltd is ₹ 798.4 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Solara Active Pharma Sciences Ltd

No data available

Company Fundamentals for Solara Active Pharma Sciences Ltd

No data available

Image

Solara Active Pharma Sciences Ltd

NSE: SOLARA

Share Price

₹ 798.4

37.15 (4.88%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Solara Active Pharma Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Solara Active Pharma Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024798.4
21 Nov 2024761.25
19 Nov 2024761.9
18 Nov 2024745.55
14 Nov 2024758.5
13 Nov 2024744.45
12 Nov 2024760.25
11 Nov 2024777.1
08 Nov 2024797.4
07 Nov 2024797.65

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Solara Active Pharma Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Solara Active Pharma Sciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Solara Active Pharma Sciences Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Solara Active Pharma Sciences Ltd

No data available

* All values are in crore

Historical Revenue of Solara Active Pharma Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Solara Active Pharma Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Solara Active Pharma Sciences Ltd

No data available

* All values are in crore

Historical Dividend Payout of Solara Active Pharma Sciences Ltd

No data available

* All values are in %

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.

Solara Active Pharma Sciences Ltd News Hub

News

Solara Active Pharma Sciences schedules AGM

Solara Active Pharma Sciences announced that the Annual General Meeting (AGM) of the compa...

Read more

2024-08-30 00:00:00

News

Solara Active Pharma Sciences reports consolidated net profit of Rs 8.01 crore in the September 2024 quarter

Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended...

Read more

2024-10-21 00:00:00

News

Solara Active Pharma Sciences allots 49,000 equity shares under ESOP

Solara Active Pharma Sciences has allotted 49,000 equity shares under ESOP on 21 October 2...

Read more

2024-10-21 00:00:00

News

Solara Active Pharma Sciences to declare Quarterly Result

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

2024-10-15 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Solara Active Pharma Sciences Ltd

What is the current PE Ratio of Solara Active Pharma Sciences Ltd?

The Current PE Ratio of Solara Active Pharma Sciences Ltd is 0.0 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Solara Active Pharma Sciences Ltd last year?

The PE Ratio of Solara Active Pharma Sciences Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Solara Active Pharma Sciences Ltd indicate about its stock?

The PE Ratio of Solara Active Pharma Sciences Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Solara Active Pharma Sciences Ltd.

What is the PE Ratio Growth of Solara Active Pharma Sciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Solara Active Pharma Sciences Ltd grew by -% whereas, the EPS ratio grew by -168.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*